• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Fact or Myth: Antioxidants Negatively Impact Iron Absorption

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Fact or Myth: Antioxidants Negatively Impact Iron Absorption

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    ESHA Research

    JRS Pharma

    Botanic Healthcare LLC

    Atlantia Clinical Trials

    Bioenergy Life Science, Inc. (BLS)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    ESHA Research

    JRS Pharma

    Botanic Healthcare LLC

    Atlantia Clinical Trials

    Bioenergy Life Science, Inc. (BLS)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Vitamin K in Focus

    Important for bone and cardiovascular health, vitamin K2 has benefited from strong science and growing awareness.

    Vitamin K in Focus
    Related CONTENT
    • Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    • Xsto Solutions
    • Balchem Agrees to Acquire Kappa Bioscience AS
    • Vitamin K Status Associated with Cognitive Test Performance in Elderly Adults
    • Gnosis by Lesaffre: The Preeminent Vitamin K2 Supplier
    By Sean Moloughney, Editor01.25.18
    Essential vitamins A, C, D and E have been common components of multivitamin formulations for decades, but a relative newcomer has seen its stock steadily rising: vitamin K.
     
    Important for optimal bone and cardiovascular health, vitamin K comprises a number of structurally related compounds, including phylloquinones (vitamin K1) and menaquinones (vitamin K2).
     
    “Vitamin K1 is known for its role in blood coagulation (clotting),” noted Eric Anderson, senior vice president of global marketing and business development, NattoPharma USA, Inc., Edison, NJ, supplier of branded MenaQ7 Vitamin K2 as MK-7. “Vitamin K2 also contributes to coagulation, but more importantly, it is now recognized for its essential role in building and maintaining strong bones, as well as inhibiting calcium deposits in the arteries and blood vessels.”
     
    All K vitamins are similar in structure, but differ in the length of the “side chain”—the longer the side chain, the better effect and efficiency, Mr. Anderson explained. “Consequently, the long-chain menaquinones (especially MK-7) are the most desirable as they are nearly completely absorbed and stay in the blood for the longest time. This makes vitamin K2 also available for tissues outside the liver, namely bones, arteries, and soft tissues.”
     
    In fact, studies consistently show that vitamin K2 as MK-7 is more effective compared to MK-4, mainly due to MK-7’s significantly greater absorption and half-life, accumulation in the serum, and efficacy.
     
    Understanding about the vitamin K forms has come a long way since the 1950s, said Dan Murray, vice president, business development, Xsto Solutions, LLC, Morristown, NJ, which supplies K2VITAL brand vitamin K2 MK-7 from Kappa Bioscience. “The challenge for K1 was the strong coagulation properties were beneficial for some, but not for all. The second generation was vitamin K2 MK-4, (menaquinone 4) offering some bone benefit with less powerful coagulation properties, but it has stability challenges and literally requires 1,000-times the dose of the more advanced form K2 MK-7. The current form of K2 MK7 (menaquinone 7) offers a more optimum package of stability, bone and heart benefits, but with reduced negative blood clotting aspects.” 
     
    Fermented foods like natto are the primary food source of vitamin K2, as well as certain cheeses and animal products, like egg yolks.
     
    Market Success
    Thanks to recent clinical research, growing consumer awareness, manufacturing efficiencies, and lower price-points, the market for vitamin K2 has been accelerating, according to experts.
     
    “We would conservatively estimate the global ingredient market for vitamin K2 is in the $30-35 million range, which as a specialty ingredient equates to about $300 million at retail,” said Mr. Anderson. “Importantly, most products today are in the bone health segment. The strength of NattoPharma’s MenaQ7 cardiovascular science is now driving heart health products globally. And the ultimate goal is multivitamins for prenatals, infant nutrition, kids, teens, and adults. This will ultimately grow the market exponentially.”
     
    The vitamin K2 market has already been growing at a “tremendous pace,” essentially doubling annually over the past few years, said Mr. Murray. “When an ingredient is new and relatively small volume this is not so difficult, but at current volumes this is impressive growth.”
     
    Several factors are coming together to support the growth trajectory of vitamin K2, he added, principally a strong body of science. “Consumer awareness for bone health started years ago with calcium. Followed by the explosive growth of vitamin D, K2 is now appreciated for the cardiovascular benefit in addition to the bone benefit. With this significant growth, manufacturers are realizing some production efficiencies and that has helped bring down raw material prices. The trifecta of good science, growing awareness, and falling prices is pulling K2 into more and more formulas.”
     
    NattoPharma has been focused on driving awareness by educating the market about the importance of vitamin K2 for human health; finished product brands have played an important role toward that end, said Mr. Anderson. “As the leader in vitamin K2 research and development, we have worked to cultivate an understanding—down to the consumer level—of the substantial evidence supporting vitamin K2 as a vital nutrient for bone and cardiovascular health. As the sponsor of this important research, these studies have utilized our branded MenaQ7 Vitamin K2 as MK-7.”
     
    Primary Beneficiaries
    In terms of consumer demographics, Luke Bucci, PhD CCN CNS, vice president of R&D for the supplement brand Ritual, noted that people age 50 and up might stand to benefit most from supplementation with vitamin K. “But all adults and children would derive a stronger, lifelong benefit. Women with a family history of bone loss and cardiovascular issues would probably benefit the most.” Ritual’s Essential for Women multivitamin/mineral includes nine essential nutrients women lack the most.
     
    “We started out with a blank slate,” Dr. Bucci said of the product’s development. “Something from which every adult woman could derive life-long benefit. We wanted a lean and efficient MVM without frills, window dressing, or herbs/foodstuffs that have microbial concerns and focusing on essentials. We set out to see what essential nutrients are needed the most, which ones have gaps between healthy and unhealthy intakes, and what is already satisfied by the available science. We also sought vegan/vegetarian sources, non-GMO, organic when possible, bioidentical/food form sources and doses to bring up intakes to those seen in healthy diets (that is, diets that help extend quality lifespan, maintain mental functions and decrease risk of major causes of mortality).”
     
    Mr. Murray agreed that with the two primary benefits being bone health and heart health, “We tend to think of the middle-age to senior population as the target market for vitamin K2. In fact, if people in their 30s take a preventive approach to healthy living, this population may be able to significantly reduce typical age-related health issues such as osteopenia/osteoporosis and cardiovascular disease.”
     
    Speaking about research trends, Mr. Anderson said numerous human clinical trials have confirmed the health benefits of vitamin K2. “NattoPharma currently has more than 20 human studies, including 19 published clinical trials confirming the benefits of vitamin K2 as MK-7 in both patient and healthy populations, with more underway.”
     
    “Most significantly, our three-year studies have shown an unprecedented impact on the health of postmenopausal women,” he added. For example, three years of daily 180 mcg MenaQ7 led to statistically significant improvement in bone mineral content and bone mineral density, leading to improved bone strength.
     
    In addition three years of daily 180 mcg MenaQ7 not only inhibited age-related stiffening of the artery walls, but also made a statistically significant improvement in vascular elasticity, he added. “This is so very significant because, to date, no other compound has demonstrated these benefits. Our studies have also confirmed that children have the greatest need for vitamin K2—8-10 times higher need than in adults (as measured by inactive osteocalcin, the K-dependent protein that binds calcium to the bone mineral matrix).
     
    Bones grow and develop most intensively during childhood and adolescence, with up to 90% of peak bone mass acquired by age 18 in girls and by age 20 in boys, Mr. Anderson noted. “Without adequate vitamin K2 to activate the bone-building osteocalcin, calcium cannot be properly used to build healthy, strong bones. Further, a two-year study in healthy prepubertal children showed that just 45-50 mcg of MenaQ7 daily improved K status, resulting in stronger, denser bones.
     
    In just the last year, several studies have expounded on the benefits of vitamin K. “The medical community has been paying attention, and drug studies are already underway using menaquinone-7,” he added.  The studies look at progression of coronary artery calcification, valve calcification, and the progression of bicuspid aortic valve stenosis.
     
    Synergies
    Vitamin K2 works synergistically with many ingredients, according to Mr. Anderson, but its core strength is its role in helping the body properly utilize calcium. Vitamin K2 as MK-7 does this by activating K-dependent proteins already in the body. Osteocalcin bind calcium to the bone mineral matrix; Matrix Gla Protein (MGP) inhibits calcium from depositing in arteries, blood vessels, and soft tissues.
     
    “To that end, vitamin D is also an important synergistic ingredient. Vitamin D helps to synthesize these K-dependent proteins, so experts like Dr. Mercola suggest that when one increases their D intake, they balance that with vitamin K2.”
     
    In addition, while omega-3's mechanism of action is linked to supporting healthy inflammation, triglycerides, blood pressure, and promotion of arterial health, it is not recognized for impacting vascular calcification, which is what makes vitamin K2 a perfect complement.
     
    NattoPharma has obtained a patent covering pharmaceutical and nutraceutical products providing vitamin K2 in combination with one or more polyunsaturated fatty acids, including fish and/or krill oil, for benefits related to bone, cartilage, and the cardiovascular system.
     
    Mr. Murray said there is a “bone health triangle” consisting of calcium, vitamin D and vitamin K. “The vitamin D mobilizes the calcium into the blood stream. From there, vitamin K plays the crucial role of redepositing the calcium into the bones. Without vitamin K2, calcium will find its way to the arteries and over time a gradual buildup calcifies the arteries for serious coronary problems. Consumers generally know they need calcium for healthy bones and the awareness for vitamin D has grown significantly. Vitamin K2 is now on this same upward path and we are just scratching the surface as we move toward the Mass Market channel.”
     
    Quality Control
    “Manufacturing pure, stable, efficacious vitamin K2 as MK-7 is a detailed, multi-step process, and it is essential that it be done correctly or the result is an ineffective—and sometimes dangerous—raw material,” Mr. Anderson said.
     
    "NattoPharma’s leadership in the vitamin K2 category is also attributed to the company developing these processes and technological breakthroughs that allows us to offer pure, all-trans MK-7. This dedication has led the research community to use MenaQ7 Vitamin K2 as MK-7 as the source material in the substantial body of research confirming vitamin K2’s health benefits.”
     
    This focus on quality also creates a material that comes at a higher price, he added. “We are seeing a lot of ‘me too’ in the vitamin K2 category. Companies are ‘borrowing’ NattoPharma’s science to say that their material offers health benefits, while offering sub-par material at a heavily discounted price. Yet, in truth, there is no evidence showing that this cheaper material is effective at all. As an industry, we cannot focus on price as the deciding factor. You truly get what you pay for, and by choosing an unproven raw material that is not clinically validated and patented, you put your brand at risk.”
     
    Mr. Murray advised brand owners that, in terms of quality of vitamin K2, it’s important to have an “all trans” product form. “As with many nutrients, there is a ‘cis’ and ‘trans’ formation, much like a right-hand and left-hand glove. Just as we can’t use two left-hand gloves, our bodies only recognize the ‘trans’ form for metabolism so the presence of ‘cis’ isomers is considered an impurity and an indication of a poor-quality vitamin K2 product. Using an HPLC assay, we hope to see a very distinct peak of trans K2 MK7 rather than a ‘head-and-shoulder’ pattern indicating cis isomers and other impurities.”
     
    Dr. Bucci noted that the Ritual brand is centered around transparency and traceability, explaining the source and manufacturer of each ingredient, including vitamin K2. “We take transparency so literally we have clear bottles and capsules. For too long, what is actually in many dietary supplements and where they come from has been hidden. Our CEO Katerina Schneider started Ritual partly because she could not know or find out exactly what she was taking and why. We proudly show on our website where each of our ingredients come from and why we chose them. In this world of too much misinformation we chose to be matter of fact.”
    Related Searches
    • Fermented
    • Bones
    • Dietary Supplements
    • Children
    Related Knowledge Center
    • Bone & Joint Health
    • Cardiovascular Health
    • Healthcare Trends
    Suggested For You
    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    Xsto Solutions Xsto Solutions
    Balchem Agrees to Acquire Kappa Bioscience AS Balchem Agrees to Acquire Kappa Bioscience AS
    Vitamin K Status Associated with Cognitive Test Performance in Elderly Adults Vitamin K Status Associated with Cognitive Test Performance in Elderly Adults
    Gnosis by Lesaffre: The Preeminent Vitamin K2 Supplier Gnosis by Lesaffre: The Preeminent Vitamin K2 Supplier
    Frezzor New Zealand Launches Vitamin D3 Sourced from Sheep’s Wool Frezzor New Zealand Launches Vitamin D3 Sourced from Sheep’s Wool
    Blue California: Delivering Sustainable, Evidence-Based Solutions for a Healthy Mind and Body Blue California: Delivering Sustainable, Evidence-Based Solutions for a Healthy Mind and Body
    Vitamin K2 Reduces Oxidative Stress, Increases ATP Production, Study Finds Vitamin K2 Reduces Oxidative Stress, Increases ATP Production, Study Finds
    Why Vegans Should Consider Supplementing with Vitamin K2 (MK-7) Why Vegans Should Consider Supplementing with Vitamin K2 (MK-7)
    Active Nutrition Market Expands to Meet Modern Health Challenges Active Nutrition Market Expands to Meet Modern Health Challenges
    Kappa BioScience Forms Scientific and Medical Advisory Board Kappa BioScience Forms Scientific and Medical Advisory Board
    ICYMI: What People Were Reading on NutraceuticalsWorld.com in January 2022 ICYMI: What People Were Reading on NutraceuticalsWorld.com in January 2022
    Vitamin and Mineral Supplements Offer A Sturdy Industry Foundation Vitamin and Mineral Supplements Offer A Sturdy Industry Foundation
    Vitamin K Status May Have Stronger Impact on COVID-19 Than Vitamin D Deficiency Vitamin K Status May Have Stronger Impact on COVID-19 Than Vitamin D Deficiency
    Gnosis by Lesaffre Launches Vitamin K2 Protective Matrix Gnosis by Lesaffre Launches Vitamin K2 Protective Matrix

    Related Breaking News

    • Breaking News | Medical Nutrition | Research | Research News | Vitamins | Women's Health
      Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

      Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

      K2 in the form of Menaquinone-7 alleviated depression and other comorbidities of PCOS in a group of 84 women.
      08.15.22

    • Xsto Solutions

      Xsto Solutions

      ...
      Dan Murray, VPBusiness Development 06.22.22

    • Breaking News | Mergers & Acquisitions | Supplier News | Vitamins | World Markets
      Balchem Agrees to Acquire Kappa Bioscience AS

      Balchem Agrees to Acquire Kappa Bioscience AS

      The vitamin K2 supplier was purchased from majority owner Verdane Edda for approximately $338 million.
      06.14.22


    • Breaking News | Cognitive Function | Medical Nutrition | Research News | Vitamins
      Vitamin K Status Associated with Cognitive Test Performance in Elderly Adults

      Vitamin K Status Associated with Cognitive Test Performance in Elderly Adults

      A study on 800 older adults found a link between cognitive function and osteocalcin, a biomarker for low vitamin K status.
      04.26.22

    • Delivery & Dosage Technologies | Dietary Supplements | Video Bites | Vitamins
      Gnosis by Lesaffre: The Preeminent Vitamin K2 Supplier

      Gnosis by Lesaffre: The Preeminent Vitamin K2 Supplier

      Global Market Manager Xavier Berger discusses the company’s new technology that will allow for the creation of more complex K2 formulations.

    Loading, Please Wait..
    Trending
    • Study Examines Vitamin K2 Content In Cheese
    • Chenland Nutritionals Self-Affirms GRAS For Cumin UP60 Ingredient
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    • ADM And Benson Hill Partner To Scale High Protein Soy For U.S. Market
    Breaking News
    • Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    • Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    • Omega-3 Fatty Acids Linked to Reduced Episodes of Depression
    • Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    • ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression
    Coatings World

    Latest Breaking News From Coatings World

    Nouryon Enters into Exclusive Agreement with Brenntag Specialties
    The BEHR & KILZ Brands Partner with Leanne Ford to Revitalize Her Historic American Home
    IGM Resins Acquires Litian
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    NeuroPace Becomes Exclusive U.S. Distributor of DIXI’s Product Line
    TransMed7 Achieves First-in-Human for Heron Soft Tissue Biopsy Devices
    West Pharmaceutical Services Invests in Latch Medical
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Societal CDMO Inks Land Sell Deal
    RoosterBio and AGC Biologics to Accelerate Manufacturing of Cell and Exosome Therapies
    WuXi Advanced Therapies Enters Licensing Agreement with Janssen
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Johnson & Johnson to Discontinue Global Sales of Talc-Based Baby Powder
    Dr. Squatch To Launch a 2nd Star Wars Soap Collection
    Neopac Wins 2 European Tube Manufacturers Association Awards
    Happi

    Latest Breaking News From Happi

    Coveteur Co-founder Erin Makes Foray into Skincare Space
    The Body Shop Canada Continues Expansion of New Concept Stores
    Nutrafol Expands Hair Care with Strand Defender Conditioner
    Ink World

    Latest Breaking News From Ink World

    Leadership Change in ALTANA’s ELANTAS Division
    Nazdar Highlights Ink Innovation at Labelexpo Americas 2022
    Cyngient, Imageworx Partner at Labelexpo for Security Labeling
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI partners with Convergen Energy at Labelexpo
    FINAT reports decrease in labelstock consumption during first half of 2022
    Color-Logic partners to feature metallics at autumn events
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Because Market Expands into Retail Stores
    Tranzonic Acquired by Private Investment Firm
    Monadnock Earns EcoVadis Gold Rating
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    FDA Clears CTL Amedica's Navigation Instrument System
    FundamentalVR Raises $20 Million in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints John Cooney to Lead Global Advocacy and Public Policy
    NMBS/SNCB Improves Security With HID Global’s Real-Time Location Service Technology
    onsemi Celebrates Expansion of Silicon Carbide Production Facility in New Hampshire

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login